PALI
Palisade Bio
$2.03
+$0.08 (+4.1%)Jul 27, 2026
Key metrics
The numbers that frame PALI today
- Market cap
- $352.37M
- P/E (TTM)
- -14.6
- EV / FCF
- -17.7
- ROIC
- 766.1%
- Div yield
- 0%
- Debt / equity
- 0.0
- 52wk Low
- $0.53
- 52wk High
- $2.86
Growth
Revenue and earnings trend for PALI
RevenueNet income
See the full growth breakdown
Revenue and earnings trends, margins and the multi-year trajectory - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inCash flow & returns
Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture
Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inInsider trading
Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade
See who is buying and selling, how much, and when - updated as new filings land.
Create a free accountFree foreverNo card required
Already a member? Log inFrequently asked questions
Plain-English answers about PALI
Is Palisade Bio a good buy?
No. Palisade Bio has strong momentum, but poor quality undercuts the setup. Growth looks weak. That could put pressure on the long-term business case. We think Palisade Bio is selling at a high price.
What is the market capitalization of PALI?
Palisade Bio's market capitalization is $352.37M.
What is the P/E ratio for PALI stock?
Palisade Bio's current P/E ratio is -14.6.
What is the 52-week high for PALI stock?
The 52-week high for Palisade Bio is $2.86. The current close of $2.03 is 28.9% below that high.
What is the 52-week low for PALI stock?
The 52-week low for Palisade Bio is $0.53. The current close of $2.03 is 283% above that low.
Does PALI stock pay dividends?
Palisade Bio does not currently show a dividend per share in the company data.
What is the Debt / Equity ratio for PALI?
Palisade Bio's Debt / Equity ratio is 0.